Adimab, LLC - 17 Nov 2025 SCHEDULE 13D/A Report for Invivyd, Inc. Common Stock, $0.0001 par value per share (IVVD)

Filing Manager: Adimab, LLC
Reporting Manager: Adimab, LLC
Security: Invivyd, Inc. Common Stock, $0.0001 par value per share
Symbol: IVVD
Shares outstanding: 232,437,386 shares
Disclosed Ownership: 20,454,490 shares
Ownership: 8.8%
Form type: SCHEDULE 13D/A
Filing time: 19 Nov 2025, 16:30:23 UTC
Date of event: 17 Nov 2025
Next filing: 29 Dec 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Adimab, LLC	8.8%	20,454,490	20,454,490		/s/ Philip Chase	Philip Chase, Chief Executive Officer	0001545672